title: A hemolytic assay for clinical investigation of human C2.
abstract: The heat lability of early acting components of human complement was studied in detail. Kinetic disappearance of individual components was monitored by hemolytic assay. C2 and factor B were the most heat labile components. We took advantage of the difference in heat stability between C2 and C1 to develop a hemolytic assay for human C2.
mesh_terms: D000818:Animals; D003167:Complement Activation; D003175:Complement C2 / Q000032:analysis / Q000172:deficiency*; D004306:Dose-Response Relationship, Immunologic; D006168:Guinea Pigs; D006461:Hemolysis; D006801:Humans; D007700:Kinetics; D013696:Temperature
chemical_list: D003175:Complement C2